Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 70Prostatic Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Lymphedema 4Triple Negative Breast Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Anxiety Disorders 3Uterine Cervical Neoplasms 2Melanoma 2Fatigue 2Depression 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Breast Cancer Metastatic 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1TNBC 1Stroke 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Spinal Stenosis 1Spinal Cord Injuries 1Small Cell Lung Carcinoma 1

Interventions

Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Esophagitis × Breast × Clear all
NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation
90 enrolled
BreastOther

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡